Genes implicated in bacterial stress responses have been used to construct models that infer the growth outcome of a bacterium in the presence of antibiotics with the objective to develop novel diagnostic methods in the clinic. Current models are trained on data specific to a species or type of stress, making them potentially limited in their application. It is unclear if a generalizable response-signature exists that can predict bacterial fitness independent of strain, species or type of stress. Here we present a substantial RNA-Seq and experimental evolution dataset for 9 strains and species, under multiple antibiotic and non-antibiotic stress conditions. We show that gene panel-based models can accurately predict antibiotic mechanism of action, as well as the fitness outcome of Streptococcus pneumoniae in the presence of antibiotics or under nutrient depletion. However, these models quickly become species-specific as gene homology is limited. Instead, we define a new concept, transcriptomic entropy, which we use to quantify the amount of transcriptional disruption that occurs in a bacterium when responding to the environment. With entropy at the center, we train a suite of predictive (machine learning) models enabling generalizable fitness and antibiotic sensitivity predictions. These entropy-based models that predict bacterial fitness are validated for 7 Gram-positive and -negative species under antibiotic and non-antibiotic conditions indicating that transcriptomic entropy can be used as a generalizable stress signature. Moreover, rather than being a binary indicator of fitness, an entropy-based model was developed and validated to predict the minimum inhibitory concentration of an antibiotic. Lastly, we show that the inclusion of a varied-set of multi-omics features of a bacterial stress response further enhances fitness predictions by reducing ambiguity. By demonstrating the feasibility of generalizable predictions of bacterial fitness, this work establishes the fundamentals for potentially new approaches in infectious disease diagnostics, including antibiotic susceptibility testing. Significance statement: Accurate predictions of bacterial fitness outcome could potentially have clinical diagnostic value, such as predicting optimum antibiotic choice and dosage for treating infectious diseases. Existing models of fitness predictions rely mainly on gene panel approaches, which may be species- and stress-specific due to a lack of gene and response conservation. In order to overcome this limitation, we generated a substantial experimental dataset and identified entropy as a universal stress response signature that quantifies the level of transcriptional disruption that is indicative of fitness outcome under a stressful condition. We present and validate for Gram-positive and negative species a suite of entropy-based models that enable accurate predictions of fitness outcome and the level of antibiotic sensitivity in a species and stress-type independent manner.
The rapid increase in antibiotic resistant pathogenic bacteria has become a global threat, which besides the development of new drugs, requires rapid, cheap, scalable, and accurate diagnostics. Label free biosensors relying on electrochemical, mechanical, and mass based detection of whole bacterial cells have attempted to meet these requirements. However, the trade-off between selectivity and sensitivity of such sensors remains a key challenge. In particular, point-of-care diagnostics that are able to reduce and/or prevent unneeded antibiotic prescriptions require highly specific probes with sensitive and accurate transducers that can be miniaturized and multiplexed, and that are easy to operate and cheap. Towards achieving this goal, we present a number of advances in the use of graphene field effect transistors (G-FET) including the first use of peptide probes to electrically detect antibiotic resistant bacteria in a highly specific manner. In addition, we dramatically reduce the needed concentration for detection by employing dielectrophoresis for the first time in a G-FET, allowing us to monitor changes in the Dirac point due to individual bacterial cells. Specifically, we realized rapid binding of bacterial cells to a G-FET by electrical field guiding to the device to realize an overall 3 order of magnitude decrease in cell-concentration enabling a single-cell detection limit, and 9-fold reduction in needed time to 5 minutes. Utilizing our new biosensor and procedures, we demonstrate the first selective, electrical detection of the pathogenic bacterial species Staphylococcus aureus and antibiotic resistant Acinetobacter baumannii on a single platform.
Human carbonic anhydrase 1 (CA1) has been suggested as a biomarker for identification of several diseases including cancers, pancreatitis, diabetes, and Sjogren’s syndrome. However, the lack of a rapid, cheap, accurate, and easy-to-use quantification technique has prevented widespread utilization of CA1 for practical clinical applications. To this end, we present a label-free electronic biosensor for detection of CA1 utilizing highly sensitive graphene field effect transistors (G-FETs) as a transducer and specific RNA aptamers as a probe. The binding of CA1 with aptamers resulted in a positive shift in Dirac voltage VD of the G-FETs, the magnitude of which depended on target concentration. These aptameric G-FET biosensors showed the binding affinity ( KD ) of ∼ 2.3 ng/ml (70 pM), which is four orders lower than that reported using a gel shift assay. This lower value of KD enabled us to achieve a detection range (10 pg/ml - 100 ng/ml) which is well in line with the clinically relevant range. These highly sensitive devices allowed us to further prove their clinical relevance by successfully detecting the presence of CA1 in human saliva samples. Utilization of this label-free biosensor could facilitate the early stage identification of various diseases associated with changes in concentration of CAs.